Ledger.Open graph →
SEC Form D · Amendment · filed June 21, 2022

VistaPath Biosystems, Inc

Offering
$7.4M
Sold
$7.4M
Exemption
Rule 506(b)
Industry
Other Technology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Timothy Spong · Cambridge, MAExec · DirectorBenjamin Burley · Cambridge, MAExec · DirectorLaura Benjamin · Boston, MAExec · DirectorNathan Dingler · LOS ALTOS, CAExec · DirectorIan Morell · KIRKLAND, WAExec · DirectorFred Rea · KIRKLAND, WAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗